<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02571426</url>
  </required_header>
  <id_info>
    <org_study_id>SRC52320142569-1</org_study_id>
    <nct_id>NCT02571426</nct_id>
  </id_info>
  <brief_title>Renal Function During Pediatric Anesthesia</brief_title>
  <official_title>The Influence of Propofol and Sevoflurane Anesthesia on Water and Sodium Retention in Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Uppsala University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Uppsala University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      It is known that volatile anesthesia, such as sevoflurane, retain water and that this appears&#xD;
      more pronounced in children. However, the mechanisms for this effect is unknown and it is not&#xD;
      clear if the commonly used anesthetic propofol does the same. In this study the investigators&#xD;
      want to compare the fluid and electrolyte conserving effects of sevoflurane and propofol in a&#xD;
      pediatric setting and also investigate humoral changes induced by these anesthetics.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prior studies by the investigators research group have shown water and sodium retention in&#xD;
      experimental animals undergoing sevoflurane anesthesia. Preliminary data suggest that this is&#xD;
      not as obvious with propofol anesthesia. The investigators aim to study if this difference is&#xD;
      present in children.&#xD;
&#xD;
      Subjects are collected from ordinary routine operations of hypospadia. By routine, all boys&#xD;
      undergoing this surgery get a sacral blockade and a urine catheter. The children are&#xD;
      randomized to either sevoflurane or propofol anesthesia. Before or immediately after&#xD;
      induction of anesthesia baseline blood samples are collected for analysis of sodium,&#xD;
      potassium, creatinine, osmolality, angiotensin II, arginine-vasopressin and aldosterone.&#xD;
      Perioperative fluids are started, a balanced glucose infusion with 132mmol sodium content,&#xD;
      covering basal fluid need + 20%. This infusion is continued until the end of the protocol at&#xD;
      the ward. At the induction of anesthesia the investigators start measuring urine output every&#xD;
      20th minute. The same blood samples as above are collected again during mid-operation. At the&#xD;
      end of anesthesia the investigators collect all the urine and send a sample for urine&#xD;
      analysis of sodium, potassium, osmolality and creatinine.&#xD;
&#xD;
      In the postoperative ward the investigators again start collecting urine every 20 minutes for&#xD;
      120 minutes. All urine after 120 minutes are collected, and a sample sent for analysis. After&#xD;
      60 minutes at the postoperative ward, blood samples are again collected for analysis.&#xD;
&#xD;
      In the childrens ward the protocol for the postoperative ward is repeated, with urine&#xD;
      collection and sample, as well as blood samples. After 120 minutes the protocol ends.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2015</start_date>
  <completion_date type="Actual">April 2019</completion_date>
  <primary_completion_date type="Actual">March 2018</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>urine output during anesthesia</measure>
    <time_frame>2 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>urine output postoperatively</measure>
    <time_frame>4 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>sodium excretion postoperatively</measure>
    <time_frame>4 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in aldosterone, angiotensin II, arginine-vasopressin during surgery</measure>
    <time_frame>2 hours</time_frame>
    <description>Comparison of blood samples of fluid balance regulatory hormones collected at baseline, during surgery and 1 hour + 3 hours postoperatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in aldosterone, angiotensin II, arginine-vasopressin postoperatively</measure>
    <time_frame>4 hours</time_frame>
    <description>Comparison of blood samples of fluid balance regulatory hormones collected at baseline, during surgery and 1 hour + 3 hours postoperatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sodium excretion during anesthesia</measure>
    <time_frame>2 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Renal Failure</condition>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>Propofol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Continuous infusion during surgery. Individual dosage.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sevoflurane</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Inhalational anesthetic during surgery. Individual dosage</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane</intervention_name>
    <description>anesthetic agent</description>
    <arm_group_label>sevoflurane</arm_group_label>
    <other_name>sevorane</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>propofol</intervention_name>
    <description>anesthetic agent</description>
    <arm_group_label>Propofol</arm_group_label>
    <other_name>diprivane</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Eligible for hypospadia surgery.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  American Association of Anesthesiology class above 2&#xD;
&#xD;
          -  Weight above 50 kg or below 10 kg&#xD;
&#xD;
          -  Hypersensitivity towards the anesthetic agents (difficult peanut or soy allergy)&#xD;
&#xD;
          -  Inability for parent to understand study information&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Micael Taavo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Uppsala University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Akademiska university hospital</name>
      <address>
        <city>Uppsala</city>
        <zip>75185</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>October 5, 2015</study_first_submitted>
  <study_first_submitted_qc>October 6, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 8, 2015</study_first_posted>
  <last_update_submitted>November 2, 2020</last_update_submitted>
  <last_update_submitted_qc>November 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Uppsala University</investigator_affiliation>
    <investigator_full_name>Micael Taavo</investigator_full_name>
    <investigator_title>Staff physician</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Renal Insufficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

